Case report: Non-oral treatment with ivermectin for disseminated strongyloidiasis Academic Article uri icon

Overview

MeSH Major

  • Antiparasitic Agents
  • Ivermectin
  • Strongyloidiasis

abstract

  • Critically ill patients with disseminated strongyloidiasis may not be candidates for oral treatment. We report four patients with disseminated strongyloidiasis, believed to be unable to absorb oral therapy, who were treated with ivermectin by rectal and/or subcutaneous administration. Obtaining subcutaneous ivermectin and dosing it appropriately is a challenge. These cases underscore the need for improved access to subcutaneous ivermectin and more pharmacological data to guide use of this treatment approach.

publication date

  • October 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2946761

Digital Object Identifier (DOI)

  • 10.4269/ajtmh.2010.10-0258

PubMed ID

  • 20889884

Additional Document Info

start page

  • 879

end page

  • 83

volume

  • 83

number

  • 4